Cargando…
High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
INTRODUCTION: HIV and HCV risk behaviors among injection drug users (IDUs) in two urban areas in Pakistan were identified. METHODS: From May to June 2003, 351 IDUs recruited in harm-reduction drop-in centers operated by a national non-governmental organization in Lahore (Punjab province) and Quetta...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564387/ https://www.ncbi.nlm.nih.gov/pubmed/16914042 http://dx.doi.org/10.1186/1477-7517-3-26 |
_version_ | 1782129561170870272 |
---|---|
author | Kuo, Irene ul-Hasan, Salman Galai, Noya Thomas, David L Zafar, Tariq Ahmed, Mohammad A Strathdee, Steffanie A |
author_facet | Kuo, Irene ul-Hasan, Salman Galai, Noya Thomas, David L Zafar, Tariq Ahmed, Mohammad A Strathdee, Steffanie A |
author_sort | Kuo, Irene |
collection | PubMed |
description | INTRODUCTION: HIV and HCV risk behaviors among injection drug users (IDUs) in two urban areas in Pakistan were identified. METHODS: From May to June 2003, 351 IDUs recruited in harm-reduction drop-in centers operated by a national non-governmental organization in Lahore (Punjab province) and Quetta (Balochistan province) completed an interviewer-administered survey and were tested for HIV and HCV. Multivariable logistic regression identified correlates of seropositivity, stratifying by site. All study participants provided written, informed consent. RESULTS: All but two were male; median age was 35 and <50% had any formal education. None were HIV-positive; HCV seroprevalence was 88%. HIV awareness was relatively high, but HCV awareness was low (19%). Injection behaviors and percutaneous exposures such as drawing blood into a syringe while injecting ('jerking'), longer duration of injection, and receiving a street barber shave were significantly associated with HCV seropositivity. DISCUSSION: Despite no HIV cases, overall HCV prevalence was very high, signaling the potential for a future HIV epidemic among IDUs across Pakistan. Programs to increase needle exchange, drug treatment and HIV and HCV awareness should be implemented immediately. |
format | Text |
id | pubmed-1564387 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15643872006-09-14 High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan Kuo, Irene ul-Hasan, Salman Galai, Noya Thomas, David L Zafar, Tariq Ahmed, Mohammad A Strathdee, Steffanie A Harm Reduct J Research INTRODUCTION: HIV and HCV risk behaviors among injection drug users (IDUs) in two urban areas in Pakistan were identified. METHODS: From May to June 2003, 351 IDUs recruited in harm-reduction drop-in centers operated by a national non-governmental organization in Lahore (Punjab province) and Quetta (Balochistan province) completed an interviewer-administered survey and were tested for HIV and HCV. Multivariable logistic regression identified correlates of seropositivity, stratifying by site. All study participants provided written, informed consent. RESULTS: All but two were male; median age was 35 and <50% had any formal education. None were HIV-positive; HCV seroprevalence was 88%. HIV awareness was relatively high, but HCV awareness was low (19%). Injection behaviors and percutaneous exposures such as drawing blood into a syringe while injecting ('jerking'), longer duration of injection, and receiving a street barber shave were significantly associated with HCV seropositivity. DISCUSSION: Despite no HIV cases, overall HCV prevalence was very high, signaling the potential for a future HIV epidemic among IDUs across Pakistan. Programs to increase needle exchange, drug treatment and HIV and HCV awareness should be implemented immediately. BioMed Central 2006-08-16 /pmc/articles/PMC1564387/ /pubmed/16914042 http://dx.doi.org/10.1186/1477-7517-3-26 Text en Copyright © 2006 Kuo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Kuo, Irene ul-Hasan, Salman Galai, Noya Thomas, David L Zafar, Tariq Ahmed, Mohammad A Strathdee, Steffanie A High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan |
title | High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan |
title_full | High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan |
title_fullStr | High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan |
title_full_unstemmed | High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan |
title_short | High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan |
title_sort | high hcv seroprevalence and hiv drug use risk behaviors among injection drug users in pakistan |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564387/ https://www.ncbi.nlm.nih.gov/pubmed/16914042 http://dx.doi.org/10.1186/1477-7517-3-26 |
work_keys_str_mv | AT kuoirene highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan AT ulhasansalman highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan AT galainoya highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan AT thomasdavidl highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan AT zafartariq highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan AT ahmedmohammada highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan AT strathdeesteffaniea highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan |